SCD48 is anti-inflammatory in Staphylococcus aureus Enterotoxin B-induced eosinophilic inflammation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 6, 2016, Pages 829-839

  Gangwar, R S ^a   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

CD48; eosinophils, inflammation; peritonitis; SEB

Indexed keywords

BREFELDIN A; CD11B ANTIGEN; CD48 ANTIGEN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; PHOSPHOLIPASE C; PHOSPHOLIPASE D; STAPHYLOCOCCUS ENTEROTOXIN B; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; PHOSPHOLIPASE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CHEMOTAXIS; CYTOKINE RELEASE; DOWN REGULATION; EOSINOPHIL; EOSINOPHILIC INFLAMMATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM LAVAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BLOOD; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PROTEIN DEGRADATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; CD48 ANTIGEN; CHEMOTAXIS; DISEASE MODELS, ANIMAL; ENTEROTOXINS; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LEUKOCYTE COUNT; MICE; PERITONITIS; PHOSPHOLIPASES; PROTEIN BINDING; PROTEOLYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC;

EID: 84960969310     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12851     Document Type: Article

References (46)

1. Allen HB, Vaze ND, Choi C, Hailu T, Tulbert BH, Cusack CA, et al., The presence and impact of biofilm-producing staphylococci in atopic dermatitis. JAMA Dermatol 2014; 150: 260-265.
2. Pastacaldi C, Lewis P, Howarth P,. Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta-analysis. Allergy 2011; 66: 549-555.
3. Tanaka A, Suzuki S, Ohta S, Manabe R, Furukawa H, Kuwahara N, et al., Association between specific IgE to Staphylococcus aureus enterotoxins A and B and asthma control. Ann Allergy Asthma Immunol 2015; 115: 191-197.
4. Ueki S, Konno Y, Takeda M, Moritoki Y, Hirokawa M, Matsuwaki Y, et al., Eosinophil extracellular trap cell death-derived DNA traps: their presence in secretions and functional attributes. J Allergy Clin Immunol 2015; 137: 258-267.
5. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F,. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006; 107: 1996-2003.
6. Takeda K, Shiraishi Y, Ashino S, Han J, Jia Y, Wang M, et al., Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol 2015; 135: 451-460.
7. Krakauer T, Stiles BG,. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence 2013; 4: 759-773.
8. Plekhova NG, Somova LM, Drobot EI,. The metabolism of the innate immunity cells in bacterial infections. Biomed Khim 2015; 61: 105-114.
9. Kumar S, Colpitts SL, Menoret A, Budelsky AL, Lefrancois L, Vella AT,. Rapid alphabeta T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A. Mucosal Immunol 2013; 6: 1006-1015.
10. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F,. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008; 76: 4489-4497.
11. Minai-Fleminger Y, Gangwar RS, Migalovich-Sheikhet H, Seaf M, Leibovici V, Hollander N, et al., The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation. Clin Exp Allergy 2014; 44: 1335-1346.
12. Wedi B, Wieczorek D, Stunkel T, Breuer K, Kapp A,. Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol 2002; 109: 477-484.
13. De Nardo D,. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine 2015; 74: 181-189.
14. Elishmereni M, Levi-Schaffer F,. CD48: a co-stimulatory receptor of immunity. Int J Biochem Cell Biol 2011; 43: 25-28.
15. Mathew SO, Kumaresan PR, Lee JK, Huynh VT, Mathew PA,. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells. J Immunol 2005; 175: 1005-1013.
16. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, et al., 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 2005; 174: 110-118.
17. Munitz A, Bachelet I, Eliashar R, Khodoun M, Finkelman FD, Rothenberg ME, et al., CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol 2006; 177: 77-83.
18. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al., Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111: 1863-1874.
19. Elishmereni M, Alenius HT, Bradding P, Mizrahi S, Shikotra A, Minai-Fleminger Y, et al., Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011; 66: 376-385.
20. Ha SG, Ge XN, Bahaie NS, Kang BN, Rao A, Rao SP, et al., ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48. Nat Commun 2013; 4: 2479.
21. Smith GM, Biggs J, Norris B, Anderson-Stewart P, Ward R,. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol 1997; 17: 502-509.
22. Elishmereni M, Fyhrquist N, Singh Gangwar R, Lehtimaki S, Alenius H, Levi-Schaffer F,. Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation. J Invest Dermatol 2014; 134: 2928-2937.
23. Cheng J, Goldstein R, Stec B, Gershenson A, Roberts MF,. Competition between anion binding and dimerization modulates Staphylococcus aureus phosphatidylinositol-specific phospholipase C enzymatic activity. J Biol Chem 2012; 287: 40317-40327.
24. White MJ, Boyd JM, Horswill AR, Nauseef WM,. Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils. Infect Immun 2014; 82: 1559-1571.
25. Doery HM, Magnusson BJ, Gulasekharam J, Pearson JE,. The properties of phospholipase enzymes in staphylococcal toxins. J Gen Microbiol 1965; 40: 283-296.
26. Doery HM, Magnusson BJ, Cheyne IM, Sulasekharam J,. A phospholipase in staphylococcal toxin which hydrolyses sphingomyelin. Nature 1963; 198: 1091-1092.
27. Hallstrand TS, Lai Y, Hooper KA, Oslund RC, Altemeier WA, Matute-Bello G, et al., Endogenous secreted phospholipase A group X regulates cysteinyl leukotrienes synthesis by human eosinophils. J Allergy Clin Immunol 2015; 137: 268-277.
28. Perkins RS, Lindsay MA, Barnes PJ, Giembycz MA,. Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2 +, protein kinase C and phospholipases C and D. Biochem J 1995; 310: 795-806.
29. Geering B, Stoeckle C, Conus S, Simon HU,. Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends Immunol 2013; 34: 398-409.
30. Rothenberg ME, Hogan SP,. The eosinophil. Annu Rev Immunol 2006; 24: 147-174.
31. Minai-Fleminger Y, Gutgold A, Barhoum A, Eliashar R, Leibovici V, Berkman N, et al., Mechanisms of asthma and allergic disease-1072: CD48: a novel biomarker for asthma? World Allergy Organ J 2013; 6 (Suppl 1): P69.
32. Brunner G, Metz CN, Nguyen H, Gabrilove J, Patel SR, Davitz MA, et al., An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood 1994; 83: 2115-2125.
33. Metz CN, Brunner G, Choi-Muira NH, Nguyen H, Gabrilove J, Caras IW, et al., Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 1994; 13: 1741-1751.
34. Fink D, Contreras ML, Lelkes PI, Lazarovici P,. Staphylococcus aureus alpha-toxin activates phospholipases and induces a Ca2 + influx in PC12 cells. Cell Signal 1989; 1: 387-393.
35. Sarri E, Bockmann I, Kempter U, Valeva A, von Eichel-Streiber C, Weichel O, et al., Regulation of phospholipase D activity in synaptosomes permeabilized with Staphylococcus aureus alpha-toxin. FEBS Lett 1998; 440: 287-290.
36. Durkin JP, Shier WT,. Staphylococcal delta toxin stimulates endogenous phospholipase A2 activity and prostaglandin synthesis in fibroblasts. Biochim Biophys Acta 1981; 663: 467-479.
37. Bueno C, Lemke CD, Criado G, Baroja ML, Ferguson SS, Rahman AK, et al., Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent PLC-beta-mediated pathway. Immunity 2006; 25: 67-78.
38. Zalevsky J, Secher T, Ezhevsky SA, Janot L, Steed PM, O'Brien C, et al., Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol 2007; 179: 1872-1883.
39. Burger D, Chicheportiche R, Giri JG, Dayer JM,. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 1995; 96: 38-41.
40. Ortonne N, Ram-Wolff C, Giustiniani J, Marie-Cardine A, Bagot M, Mecheri S, et al., Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160. J Invest Dermatol 2011; 131: 916-924.
41. Giustiniani J, Marie-Cardine A, Bensussan A,. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol 2007; 178: 1293-1300.
42. Xiao Z, Wu L, Mo H, Kong T,. Increased T cell chemotaxis response to Staphylococcus enterotoxin B mediated human endothelial cell damage in vitro. Scand J Immunol 2012; 75: 147-156.
43. Desouza IA, Franco-Penteado CF, Camargo EA, Lima CS, Teixeira SA, Muscara MN, et al., Acute pulmonary inflammation induced by exposure of the airways to staphylococcal enterotoxin type B in rats. Toxicol Appl Pharmacol 2006; 217: 107-113.
44. El-Shazly AE, Henket M, Lefebvre PP, Louis R,. 2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. Int J Immunopathol Pharmacol 2011; 24: 949-960.
45. Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, et al., Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 2007; 13: 725-729.
46. Arad G, Levy R, Hillman D, Kaempfer R,. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med 2000; 6: 414-421.